ArticlePharmaceuticals (Basel, Switzerland)2023

Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients.

Nour Shbaklo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.